Edgewise Therapeutics falls after pricing $200M offering
Source: SeekingAlpha
2025-04-02 07:03:44 ET
More on Edgewise Therapeutics
- Edgewise Therapeutics: More Expensive Now, But Much More Derisked
- Edgewise rated as a new Hold at Stifel on a balanced risk-reward setup
Read the full article on Seeking Alpha
For further details see:
Edgewise Therapeutics falls after pricing $200M offering
Edgewise Therapeutics Inc.
NASDAQ: EWTX
EWTX Trading
-3.65% G/L:
$37.63 Last:
906,324 Volume:
$40 Open:
EWTX Latest News
EWTX Stock Data
$3,280,862,770
54,628,112
N/A
52
N/A
Biotechnology & Life Sciences
Healthcare
US
Boulder
